Einstein's cancer program offers state-of-the-art treatment for blood disorders. You receive expert care from physicians who are all trained and board certified in both hematology and oncology.
We treat these cancers of the blood:
- Leukemia
- Lymphoma (Hodgkins and Non-Hodgkins)
- Myeloma
Comprehensive diagnosis
Your diagnosis is determined using a variety of tests and technologies, and may include:
- Blood test
- Lymph node test
- Bone marrow biopsy
- Computed tomography (CT or CAT scans)
- Magnetic resonance imaging (MRI) that uses high-field tesla magnets to obtain the most precise images
- Positron emission tomography (PET scan)
Advanced options for treatment
Cancer is a complex disease that often requires multiple types of treatment. Your care plan at Einstein may include:
Chemotherapy
- Einstein offers targeted chemotherapy, a more precise treatment that attacks your cancer cells while minimizing side effects.
- Chemotherapy is available at Einstein on both an inpatient and outpatient basis.
Immunotherapy
- Immunotherapy, also known as biotherapy, uses your body's own immune system to help fight your blood cancer. This treatment can include the administration of therapeutic antibodies, cancer vaccines, lymphocyte infusion, or natural chemicals known as interferons and interleukins.
Radiation therapy
Surgery
- A procedure to remove all or part of your cancer.
Cancer care provided by a team of experts
Your treatment plan is created in collaborative fashion by Einstein's hematology oncology team, to ensure all variables of your condition are considered. The hematology oncology team also works with you and your family to develop and implement a program to meet your individual needs.
Access to clinical trials
Our ongoing program of clinical trials may provide you with the opportunity to take advantage of experimental drugs that offer new or improved cancer treatments.
You may also benefit from our participation in several research cooperatives, including the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group, two of the largest clinical research organizations in the United States, as well as a joint venture between the Einstein Cancer Center and Kimmel Cancer Center At Jefferson.